Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.

by Cristina Vazquez-Mateo, Justin Collins, Sarah J Goldberg, Maxx Lawson, Jaileene Hernandez-Escalante, Hans Dooms
Published 2019-01-01